Duopharma in talks for another contract extension

Duopharma expansion

PETALING JAYA: Duopharma Biotech Bhd, which has obtained a 25-month extension on a government contract, said it is in discussion with the government for an extension of its insulin contract which will expire this year.

Without going into details, group managing director Leonard Ariff Abdul Shatar told StarBiz that: “As far as the insulin contract is concerned, Duopharma and its partner Biocon have already started discussions for further extension of the contract.”

Duopharma Biotech Bhd group managing director Leonard Ariff Abdul Shatar